More or less cash for US biotech

On April 9, the Bush administration submitted a detailed version of his fiscal year (FY) 2002 budget request, boosting his initial proposal for the US National Institutes of Health (NIH; Bethesda, MD) by more than $1.5 billion to $24.674 billion (Nat. Biotechnol. 19, 290, 2001). Highlights of biotech interest within the revised NIH budget proposal include $40 million for the new National Institute of Biomedical Imaging and Bioengineering, and a 12% increase (to $427 million) for the National Human Genome Research Institute. Meanwhile, within the National Science Foundation (Arlington, VA), the overall budget request for biological sciences research remains unchanged at $483 million, as does plant genome funding at $65 million; however, $20 million of that will go toward the Arabidopsis thaliana functional genomics effort, up from $5 million in 2001. Funds for new collaborations have been suspended within the Commerce Department's Advanced Technology Program (Gaithersburg, MD)—which includes biotech research—but prior year awards will continue. The broader program within the Department of Energy that supports genome research will drop 10% to $443 million.

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Fox, J. More or less cash for US biotech. Nat Biotechnol 19, 399 (2001). https://doi.org/10.1038/88027

Download citation

Search

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing